Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Furuhashi K, Yagi A, Saiki H, Yasuma T, Okano T, Tomaru A, Tanigawa M, Yoshida M, Hataji O, Ibata H, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T.
Nishimura T, et al. Among authors: tanigawa m.
Cancer Med. 2024 Apr;13(8):e7188. doi: 10.1002/cam4.7188.
Cancer Med. 2024.
PMID: 38629295
Free PMC article.